Protagonist Therapeutics, Inc — Director's Dealing 2016

Sep 29, 2016

SEC Form 4/A — Form 4/A

Issuer: Protagonist Therapeutics, Inc (PTGX)
CIK: 0001377121
Period of Report: 2016-09-13

Reporting Person: KHOSLA CHAITAN PHD (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-09-13	Stock Option (right to buy)	$12.88	A	5000	Acquired	2026-09-13	Common Stock (5000)	Direct

Footnotes

F1: This option was inadvertently omitted from the Reporting Person's original Form 4 filed with the SEC on September 15, 2016.

F2: The shares subject to the option shall vest in equal monthly installments over a one-year period from the vesting commencement date of August 10, 2016.